
GENE MAPPING IN AN ANOPHTHALMIC PEDIGREE
OF A CONSANGUINEOUS PAKISTANI FAMILY
OPENED NEW HORIZONS FOR RESEARCH Saleha S, Ajmal M, Zafar S, Hameed A *Corresponding Author: Dr. Shamim Saleha, Department of Biotechnology and Genetic Engineering, Kohat
University of Science and Technology, Kohat 26000, Khyber Paktunkhwa, Pakistan. Tel: +92-922-5291-4659.
Cell: +92-333-964-2532. Fax: +92-922-554-556. E-mail: shamimsaleha@yahoo.com page: 77
|
RESULTS
In an ascertained consanguineous family with
isolated clinical anophthalmia, the phenotypically normal parents with pedigree ID 2MOP001and
2MOP002, produced two affected daughters with
pedigree ID 2MOP003 and 2MOP 006 (Figure 3).
The proband, (2MOP003), was the first daughter
identified with bilateral clinical anophthalmia, and
she helped in tracing the disease in this family. Bilateral
clinical anophthalmia was present at birth in
both the affected daughters and the ages of these
affected daughters were between 4-13 years.
In this study, no evidence of linkage was observed
with any of the STR markers for the 14q32,
14q24.3, 18q 21.3 and 14q21-22 loci and were
therefore excluded. However, in view of the obtained
results, this family with clinical anophthalmia
was mapped to a locus on chromosome 3q26.3-q27,
where the SOX2 gene resides, as affected daughters
showed homozygosity for this locus within a 3 cM
(centimorgan) in this region for STR markers D3S
2427, D3S1262, D1S2436 and D3S1580 (Figure 4).
In the pedigree under study, the parents of the affected
daughters were first cousins, and both carried
the same disease chromosome in a heterozygous
state (Figure 3). However, the mutations were not
identified in the single exonic sequence and regulatory
element of the SOX2 gene by comprehensive
mutational analysis of both normal and affected individuals.
Only two individuals were found to be affected,
thus, the Lod score genes could not be calculated
to examine the combined effects of the genes.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|